{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:25:34Z","timestamp":1792689934601,"version":"4.5.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No.81971508, No.81471589, No. 81273259"],"award-info":[{"award-number":["No.81971508, No.81471589, No. 81273259"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Acute promyelocytic leukemia (APL) with myelofibrosis (MF) is rare, and only 14 cases have been reported in the literature to date.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 42-year-old woman was admitted to the hospital with easy bruising and excessive bleeding. With the remission of the primary disease during treatment, the degree of fibrosis did not decrease, but worsened progressively.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>The woman was diagnosed with acute promyelocytic leukemia with secondary myelofibrosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>All-trans retinoic acid (ATRA) was discontinued after 6\u200amonths of complete remission of APL. Arsenic trioxide (ATO) was discontinued because of supraventricular tachycardia 9\u200amonths after complete remission of APL.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After withdrawal of ATRA for 2\u200amonths, the degree of fibrosis was significantly alleviated, and after withdrawal of ATRA for 8\u200amonths and ATO for 5\u200amonths, bone marrow biopsy showed no reticular fiber deposition.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>In this case report and review of an additional 14 cases of APL with MF, we highlighted the importance of the degree of MF to be evaluated by bone marrow biopsy at the time of bone marrow aspiration when APL is suspected. If MF is present, the type of MF should be determined in a timely manner, and appropriate intervention measures should be taken accordingly.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000024567","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T13:05:26Z","timestamp":1617195926000},"page":"e24567","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Acute promyelocytic leukemia with myelofibrosis"],"prefix":"10.1097","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7424-3246","authenticated-orcid":false,"given":"Mengyu","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Hematology, Zhengzhou University People's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Hematology, First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaona","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhengzhou University People's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhengzhou University People's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhengzhou University People's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhengzhou University People's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhengzhou University People's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liurui","family":"Dou","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhengzhou University People's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhengzhou University People's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Institute of Hematology, Henan Provincial People's Hospital, Zhengzhou, Henan, PR China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhengzhou University People's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanliang","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Zhengzhou University People's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"R1-20250524","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/s41375-018-0077-1","article-title":"Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet","volume":"32","author":"Barbui","year":"2018","journal-title":"Leukemia"},{"key":"R2-20250524","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1182\/blood.V75.7.1540.1540","article-title":"The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis","volume":"75","author":"Terui","year":"1990","journal-title":"Blood"},{"key":"R3-20250524","doi-asserted-by":"crossref","first-page":"e18811","DOI":"10.1097\/MD.0000000000018811","article-title":"Atypical myeloproliferative neoplasm with concurrent BCR-ABL1 fusion and CALR mutation: a case report and literature review","volume":"99","author":"Liu","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R4-20250524","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1600-0609.1992.tb01587.x","article-title":"Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients","volume":"48","author":"Maschek","year":"1992","journal-title":"Eur J Haematol"},{"key":"R5-20250524","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/sj.leu.2401094","article-title":"A case of cryptic acute promyelocytic leukemia","volume":"12","author":"Aventin","year":"1998","journal-title":"Leukemia"},{"key":"R6-20250524","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000041054","article-title":"Acute promyelocytic leukemia with marrow fibrosis at initial presentation: possible involvement of transforming growth factor-beta(1)","volume":"103","author":"Mori","year":"2000","journal-title":"Acta Haematol"},{"key":"R7-20250524","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/BF02982068","article-title":"A variant form of acute promyelocytic leukemia with marked myelofibrosis","volume":"74","author":"Fukuno","year":"2001","journal-title":"Int J Hematol"},{"key":"R8-20250524","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ajh.20607","article-title":"Acute promyelocytic leukemia with secondary myelofibrosis -- case report and review of the literature","volume":"81","author":"Dutta","year":"2006","journal-title":"Am J Hematol"},{"key":"R9-20250524","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.leukres.2012.02.004","article-title":"Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine","volume":"36","author":"Lu","year":"2012","journal-title":"Leuk Res"},{"key":"R10-20250524","first-page":"826894","article-title":"Acute promyelocytic leukemia presenting with severe marrow fibrosis","volume":"2015","author":"Shah","year":"2015","journal-title":"Case Rep Hematol"},{"key":"R11-20250524","first-page":"8","article-title":"Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome","volume":"4","author":"Braun","year":"2015","journal-title":"Leuk Res Rep"},{"key":"R12-20250524","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.hemonc.2016.08.001","article-title":"Acute promyelocytic leukemia with increased bone marrow reticulin fibrosis: description of three cases and review of the literature","volume":"11","author":"Abou Dalle","year":"2018","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"R13-20250524","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.pathol.2016.02.012","article-title":"Atypical presentation of therapy-related acute promyelocytic leukaemia with marrow fibrosis","volume":"48","author":"Mohamed","year":"2016","journal-title":"Pathology"},{"key":"R14-20250524","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/bjh.14738","article-title":"Primary myelofibrosis presenting in acute promyelocytic transformation","volume":"178","author":"Kwong","year":"2017","journal-title":"Br J Haematol"},{"key":"R15-20250524","first-page":"1616237","article-title":"Prolonged myelosuppression due to progressive bone marrow fibrosis in a patient with acute promyelocytic leukemia","volume":"2019","author":"Inagawa","year":"2019","journal-title":"Case Rep Hematol"},{"key":"R16-20250524","first-page":"76","article-title":"Unusual massive bone marrow fibrosis in acute promyelocytic leukemia following arsenic trioxide therapy","volume":"4","author":"Venkatesan","year":"2015","journal-title":"Leuk Res Rep"},{"key":"R17-20250524","first-page":"39","article-title":"Chinese guidelines for the diagnosis and treatment of acute promyelocytic leukemia (2018 edition)","volume":"3","year":"2018","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"R18-20250524","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/jcp.37.11.1259","article-title":"Bone marrow fibre content in acute myeloid leukaemia before and after treatment","volume":"37","author":"Islam","year":"1984","journal-title":"J Clin Pathol"},{"key":"R19-20250524","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1365-2141.1996.d01-1708.x","article-title":"Tretinoin induces bone marrow collagenous fibrosis in acute promyelocytic leukaemia: new adverse, but reversible effect","volume":"93","author":"Hatake","year":"1996","journal-title":"Br J Haematol"},{"key":"R20-20250524","doi-asserted-by":"crossref","first-page":"18820","DOI":"10.1073\/pnas.1318974110","article-title":"Rescue of a primary myelofibrosis model by retinoid-antagonist therapy","volume":"110","author":"Hong","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R21-20250524","article-title":"Platelet-derived growth factor receptor \u03b2 activation and regulation in murine myelofibrosis","author":"Kramer","year":"2019","journal-title":"Haematologica"},{"key":"R22-20250524","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1182\/blood.V88.12.4534.bloodjournal88124534","article-title":"Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia","volume":"88","author":"Le Bousse-Kerdil\u00e8s","year":"1996","journal-title":"Blood"},{"key":"R23-20250524","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/sj.onc.1203354","article-title":"Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines","volume":"19","author":"Hayakawa","year":"2000","journal-title":"Oncogene"},{"key":"R24-20250524","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood.V96.12.3907","article-title":"Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways","volume":"96","author":"Mizuki","year":"2000","journal-title":"Blood"},{"key":"R25-20250524","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.1158\/0008-5472.CAN-05-0422","article-title":"Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation","volume":"65","author":"Brandts","year":"2005","journal-title":"Cancer Res"},{"key":"R26-20250524","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ebiom.2015.04.006","article-title":"Mutations of epigenetic modifier genes as a poor prognostic factor in acute promyelocytic leukemia under treatment with all-trans retinoic acid and arsenic trioxide","volume":"2","author":"Shen","year":"2015","journal-title":"EBioMedicine"},{"key":"R27-20250524","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1080\/10428194.2020.1775212","article-title":"Arsenic trioxide and all-trans retinoic acid suppress the expression of FLT3-ITD","volume":"61","author":"Liang","year":"2020","journal-title":"Leuk Lymphoma"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024567","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T17:09:40Z","timestamp":1748106580000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000024567"}},"subtitle":["A case report and literature review"],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":27,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000024567","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,2]]},"assertion":[{"value":"2020-11-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}